Press Releases Archives - Lupin

BSE 2300.00 NSE 2296.90

indian flag icon

India

USA

great-britain flag icon

UK

south-africa flag icon

South Africa

australia flag icon

Australia

philippines flag icon

Philippines

germany flag icon

Germany

netherlands flag icon

Netherlands

mexico flag icon

Mexico

brazil flag icon

Brazil

canada flag icon

Canada

Switzerland flag icon

Switzerland

BSE 2300.00 NSE 2296.90

Lupin Launches Topiramate Extended-Release Capsules in the United States

February 5, 2026

Lupin Launches Dasatinib Tablets in the United States

February 2, 2026

Lupin and TB Alliance Join Forces to Advance Telacebec for the Treatment of Tuberculosis and Other Mycobacterial Diseases

February 2, 2026

Lupin Receives Highest ESG Rating from CDP for Climate Change and Water Security

January 23, 2026

Lupin and Galenicum Sign License and Supply Agreement for Semaglutide in 23 Countries

January 21, 2026

Lupin Signs Exclusive Licensing Agreement with Gan & Lee Pharmaceuticals for novel GLP-1 receptor agonist

December 29, 2025

Lupin Signs Exclusive Licensing Agreement with Neopharmed for Gastroenterology Brand Plasil® in the Philippines and Brazil

December 18, 2025

Lupin Receives Positive CHMP Opinion for Biosimilar Ranibizumab

December 17, 2025

Lupin Receives EIR from US FDA for its Nagpur Injectable Facility

December 16, 2025

Lupin Secures SBTi Validation for Emission Reduction Targets

December 16, 2025

1 2 … 102 103

Search

Hit enter to search or ESC to close